#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Burkitt's lymphoma refractory Chronic graft versus host disease in liver Neuropathic arthropathy Duchenne muscular dystrophy Pancreatic carcinoma metastatic Usher's syndrome Parkinson's disease Polyneuropathy Cystic fibrosis Metachromatic leukodystrophy Idiopathic pulmonary fibrosis Hypereosinophilic syndrome Sjogren's syndrome Leber's congenital amaurosis Malignant glioma More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy Thrombotic thrombocytopenic purpura – Life with Disease Mucopolysaccharidosis III – Treatment Ewing’s sarcoma recurrent – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Brain stem glioma – Diagnostics Synovial sarcoma recurrent – Life with Disease Ewing’s sarcoma – Treatment Haemophilia – Diagnostics Glycogen storage disease type II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefazolin Sodium Ivonescimab Davutamig Specific Nucleic Acid Sna-Her2 Sirolimus Tivozanib Chlorpromazine Damoctocog Alfa Pegol Leriglitazone Abc-15A-116 Orlistat Ucart22 GSKVX000000039711 Sabestomig BMS-986470 Dermatophagoides Pteronyssinus Cl-Ad-Msc-002 Diclofenac Caffeine Nms-03305293 More therapies…

    Learn about Your Condition

    Myocardial infarction Postprandial hypoglycaemia Head injury Encephalopathy neonatal Inflammation Mixed dementia Migraine without aura Catatonia Fibromyalgia Mitochondrial myopathy Hodgkin's disease refractory HER2 negative breast cancer Dedifferentiated liposarcoma Herpes zoster Endometriosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Crohn’s disease

  • Study on Managing Moderate Postoperative Recurrence in Crohn’s Disease with Infliximab for Patients After Ileocolonic Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Infliximab
    Belgium France Spain

  • Study on the Safety and Effects of MBF-118 for Crohn’s Disease Patients with Stenosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mbf-118
    Spain

  • Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Ustekinumab
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn’s Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal fistula
    • Crohn’s disease
    Investigated Drugs:
    • Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
    The Netherlands Poland Spain

  • Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn’s Disease Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
    Spain

  • Study on Ustekinumab for Children with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium Germany Hungary Poland
Previous Page
1 … 13 14 15 16
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!